XML 27 R15.htm IDEA: XBRL DOCUMENT v3.25.1
Earnings Per Share and Equity Transactions
 3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Earnings Per Share and Equity Transactions Earnings Per Share and Equity Transactions
Basic earnings per share ("EPS") is computed by dividing net income or loss attributed to common shares by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that may occur from awards issued pursuant to stock-based compensation plans.
The following table reconciles the amounts used in calculating basic and diluted EPS:
Three months ended March 31
20252024
Numerator:
Net income attributed to common shares - basic and diluted$6,792 $2,900 
Denominator:
Weighted average common shares outstanding - basic77,563,971 67,874,528 
Dilutive effect of unvested restricted shares (a)596,816 397,522 
Weighted average common shares outstanding - diluted78,160,787 68,272,050 
Basic and diluted earnings per common share:
Net income per common share - basic$0.09 $0.04 
Net income per common share - diluted$0.09 $0.04 
(a)For the three months ended March 31, 2024, the Company excluded the anti-dilutive effect of market-based awards granted in 2024.

ATM Program
On March 7, 2022, the Company established an at-the-market equity offering program (the "ATM Program") through which the Company may sell from time to time up to an aggregate of $250.0 million of its common stock. In connection with the ATM Program, the Company may sell shares of its common stock to or through sales agents, or may enter into separate forward sale agreements with one of the agents, or one of their respective affiliates, as a forward purchaser. During the three months ended March 31, 2025 and 2024, no shares were issued under the ATM Program. As of March 31, 2025, $236.7 million of common stock remains available for issuance under the ATM Program.
Share Repurchase Program
On February 23, 2022, the Company established a share repurchase program (the "SRP") of up to $150.0 million of the Company's outstanding shares of common stock. The SRP may be suspended or discontinued at any time, and does not obligate the Company to repurchase any dollar amount or particular amount of shares. As of March 31, 2025, the Company has not repurchased any common stock under the SRP.